Newborn and Infant Nursing Reviews
Volume 9, Issue 1 , Pages 53-61 , March 2009

Heparin Safety in the Neonatal Intensive Care Unit: Are We Learning From Mistakes of Others?

  • Melissa Otoya, RNC BSN

      Affiliations

    • Corresponding Author InformationAddress correspondence to Melissa Otoya, RNC BSN, 2036 Vista View Lane, Crozet, VA 22932. Tel.: +1 434 823 1986.

References 

  1. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2006;29(suppl):S55–S57
  2. JC: Sentinel Event Alert . Preventing errors relating to commonly used anticoagulants. Available: http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_41.htm2008;[Accessed October 21, 2008]
  3. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children. American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest. 2008;133(6 Suppl):887s–968s(8th ed.)
  4. Hirsh J, Anand SS, Halperin JL, Valentin F. Guide to anticoagulant therapy: heparin. A statement for healthcare professionals from the American Heart Association. Circulation. 2001;103:2994–3018
  5. Malowany JI, Knoppert DC, Chan AKC, Pepelassis D, Lee DSC. Enoxaparin use in the neonatal intensive care unit: experience over 8 years. Pharmacotherapy. 2007;27:1263–1271
  6. Michaels LA, Gurian M, Hegyi T, Drachtman RA. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics. 2004;114:703–707
  7. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119:S64–S94
  8. Michelson AD, Bovill E, Monagle P, Andrew M. Antithrombotic therapy in children. Chest. 1998;114(5 Suppl):748s–769s
  9. Young TE, Mangum B. Neofax 2006. Acorn Publishing, Inc. Raleigh, NC. pp 118-119, 126-127.
  10. Shah PS, Kalyn A, Satodia P, et al. A randomized, controlled trial of heparin versus placebo infusion to prolong usability of peripherally placed percutaneous central venous catheters (PCVC's) in neonates: the HIP (Heparin infusion for PCVC) study. Pediatrics. 2007;119:e284–e291
  11. Heilskov J, Kleiber C, Johnson K, Miller J. A randomized trial of heparin and saline for maintaining locks in neonates. J Soc Pediatr Nurs. 1998;3:111–116
  12. Mok E, Kwong TKY, Chan MF. A randomized controlled trial for maintaining peripheral intravenous lock in children. Int J Nurs Pract. 2007;13:33–45
  13. Shah PS, Ng E, Sinha AK. Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database Syst Rev. 2005;CD002774
  14. Takata GS, Mason W, Taketomo C, Logsdon T, Sharek PJ. Development, testing, and findings of a pediatric-focused trigger tool to identify medication related harm in children. Pediatrics. 2008;121:e927–e935
  15. JC: Sentinel Event Alert . Preventing pediatric medication errors. Available: http://www.jointcommission.org/SentinelEvents/Sentinel/eventAlert/sea_39.htm2008;[Accessed April 14, 2008]
  16. JC: Sentinel Event Alert . Available: http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/[Accessed April 14, 2008]
  17. CBS News . 2nd baby in heparin OD cases dies. Available: http://www.cbsnews.com/stories/2008/07/10/health/main4247580.shtml?source=RSSattr=HOME_42475802008;[Accessed August 26, 2008]
  18. Hicks RW, Becker SC, Cousins DD. Harmful medication errors in children: a 5-year analysis of data from the USP's MEDMARX® program. J Pediatr Nurs. 2006;21:290–298
  19. Institute for Safe medication Practices . Medication safety alert: failure mode and effects analysis can help guide error prevention efforts. Available: http://www.ismp.org/Newsletters/acutecare/articles/20011017.asp2001;[Accessed October 21, 2008]
  20. Nelson TJ, Graves SM. 0.9% Sodium chloride injection with and without heparin for maintaining peripheral indwelling intermittent infusion devices in infants. Am J Health Syst Pharm. 1998;55:570–573
  21. Goldberg M, Givelichian L, Sankaran K. Maintaining patency of peripheral infusion devices with saline and heparinized saline. A randomized controlled trial. Pediatr Res. 1997;42:406
  22. Kotter RW. Heparin vs saline for intermittent intravenous device maintenance in neonates. Neonatal Netw. 1996;15:43–47
  23. Beecroft PC, Bossert E, Chung K, et al. Intravenous lock patency in children: dilute heparin vs saline. J Pediatr Pharm Pract. 1997;2:211–223
  24. Danek GD, Norris EM. Pediatric IV catheters: efficacy of saline flush. Pediatr Nurs. 1992;18:122–123
  25. Mudge B, Forcier D, Slattery MJ. Patency of 24-gauge peripheral intermittent infusion devices: a comparison of heparin and saline flush solutions. Pediatr Nurs. 1998;24:149
  26. Hanrahan KS, Kleiber C, Berends S. Saline for peripheral intravenous locks in neonates: evaluating a change in practice. Neonatal Netw. 2000;19:19–24
  27. McMullen A, Fioravanti ID, Pollack V, Rideout K, Sciera M. Heparinized saline or normal saline, as a flush solution in intermittent intravenous lines in infants and children. MCN Am J Matern Child Nurs. 1993;18:78–85
  28. Paisley MK, Stamper M, Brown J, Brown N, Ganong LH. The use of heparin and saline flushes in neonatal intravenous catheters. Pediatr Nurs. 1997;23:521–527

PII: S1527-3369(08)00169-4

doi: 10.1053/j.nainr.2008.12.007

Newborn and Infant Nursing Reviews
Volume 9, Issue 1 , Pages 53-61 , March 2009

Article Tools